Agilent Technologies (NYSE:A) Issues FY23 Earnings Guidance

Agilent Technologies (NYSE:AGet Rating) updated its FY23 earnings guidance on Monday. The company provided earnings per share guidance of $5.61-$5.69 for the period, compared to the consensus earnings per share estimate of $5.47. The company issued revenue guidance of $6.90-$7.00 billion, compared to the consensus revenue estimate of $7.11 billion. Agilent Technologies also updated its Q1 guidance to $1.29-$1.31 EPS.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent research reports. KeyCorp increased their target price on Agilent Technologies from $155.00 to $165.00 and gave the company an overweight rating in a research note on Tuesday. Bank of America boosted their price objective on shares of Agilent Technologies from $148.00 to $155.00 and gave the stock a buy rating in a report on Wednesday, August 17th. Cowen lifted their target price on Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday. Citigroup increased their price target on Agilent Technologies from $145.00 to $150.00 and gave the company a neutral rating in a report on Tuesday. Finally, SVB Leerink upped their target price on Agilent Technologies from $145.00 to $160.00 and gave the company an outperform rating in a research report on Tuesday. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $157.00.

Agilent Technologies Price Performance

NYSE A opened at $156.86 on Wednesday. Agilent Technologies has a 1 year low of $112.52 and a 1 year high of $162.62. The stock has a market capitalization of $46.44 billion, a P/E ratio of 35.73, a P/E/G ratio of 2.67 and a beta of 1.06. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.41 and a current ratio of 1.94. The business’s fifty day moving average is $133.55 and its two-hundred day moving average is $128.29.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.14. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The firm had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.76 billion. During the same period last year, the company posted $1.21 EPS. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. On average, research analysts forecast that Agilent Technologies will post 5.07 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be issued a dividend of $0.225 per share. The ex-dividend date is Friday, December 30th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.57%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.13%.

Insiders Place Their Bets

In related news, VP Padraig Mcdonnell sold 2,506 shares of the stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $134.33, for a total transaction of $336,630.98. Following the completion of the sale, the vice president now owns 15,320 shares in the company, valued at approximately $2,057,935.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, VP Padraig Mcdonnell sold 2,506 shares of the business’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $134.33, for a total transaction of $336,630.98. Following the transaction, the vice president now directly owns 15,320 shares in the company, valued at $2,057,935.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 6,775 shares of the stock in a transaction on Wednesday, November 16th. The shares were sold at an average price of $148.19, for a total transaction of $1,003,987.25. Following the completion of the transaction, the chief executive officer now owns 270,896 shares of the company’s stock, valued at approximately $40,144,078.24. The disclosure for this sale can be found here. Insiders sold 35,309 shares of company stock valued at $4,846,147 over the last 90 days.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Zions Bancorporation N.A. increased its holdings in Agilent Technologies by 10.8% during the 1st quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock valued at $381,000 after purchasing an additional 281 shares in the last quarter. Horizon Investments LLC lifted its holdings in Agilent Technologies by 12.6% during the 1st quarter. Horizon Investments LLC now owns 2,696 shares of the medical research company’s stock worth $356,000 after buying an additional 302 shares in the last quarter. Fund Management at Engine No. 1 LLC acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at $336,000. Mather Group LLC. lifted its stake in shares of Agilent Technologies by 13.5% during the first quarter. Mather Group LLC. now owns 2,487 shares of the medical research company’s stock valued at $329,000 after acquiring an additional 296 shares during the period. Finally, Sequoia Financial Advisors LLC increased its position in Agilent Technologies by 52.1% in the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock worth $309,000 after purchasing an additional 799 shares during the period.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Articles

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.